-
Je něco špatně v tomto záznamu ?
Long-Term Antibody Response and Vaccination Efficacy in Patients with COVID-19: A Single Center One-Year Prospective Study from the Czech Republic
M. Fajfr, R. Sleha, S. Janovska, V. Koblizek, M. Skala, S. Plisek, P. Prasil, P. Smahel, P. Bostik
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
MH-CZ DRO (UHHK, 00179906)
Ministry of Health Czech Republic
Long-term organisational development plan (DZRO)
Ministry of Defence
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
35336932
DOI
10.3390/v14030526
Knihovny.cz E-zdroje
- MeSH
- COVID-19 * diagnóza epidemiologie MeSH
- lidé MeSH
- prospektivní studie MeSH
- protilátky virové MeSH
- SARS-CoV-2 MeSH
- tvorba protilátek * MeSH
- vakcinace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: The diagnosis of SARS-CoV-2 is almost exclusively performed by PCR or antigen detection. The detection of specific antibodies has not yet been considered in official diagnostic guidelines as major laboratory evidence for a case definition. The aim the present study is to analyze antibody responses in outpatient and inpatient cohorts of COVID-19 patients in the Czech Republic over a 12-month period, and assess the potential of antibodies as a diagnostic tool. METHODS: A total of 644 patients was enrolled in the prospective study. IgA, IgM and IgG antibody levels, as well as virus neutralization titers, were analyzed over a 12-month period. RESULTS: Our study showed low antibody positivity levels at the admission. However, at 2 weeks after infection, 98.75% and 95.00% of hospitalized patients were IgA and IgG positive, respectively. Even in the outpatient cohort characterized by milder disease courses, the IgG antibody response was still sustained at 9 and 12 months. The data show a high correlation between the IgG levels and virus neutralization titers (VNTs). Samples from later time-points showed positive antibody responses after vaccination in both cohorts characterized by high IgG levels and VNT over 1:640. The samples from unvaccinated persons indicated a relatively high level of reinfection at 6.87%. CONCLUSIONS: Our results show that the detection of antibodies against the SARS-CoV-2 shows an increasing sensitivity from week 2 after infection and remains highly positive over the 12-month period. The levels of IgG antibodies correlate significantly with the VNTs. This suggests that the serological data may be a valuable tool in the diagnosis of SARS-CoV-2 infection.
Department of Infectious Diseases University Hospital 50005 Hradec Kralove Czech Republic
Department of Pneumology University Hospital 50005 Hradec Kralove Czech Republic
Faculty of Medicine in Hradec Kralove Charles University 50003 Hradec Kralove Czech Republic
Institute of Clinical Microbiology University Hospital 50005 Hradec Kralove Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019230
- 003
- CZ-PrNML
- 005
- 20220804135442.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/v14030526 $2 doi
- 035 __
- $a (PubMed)35336932
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Fajfr, Miroslav $u Institute of Clinical Microbiology, University Hospital, 50005 Hradec Kralove, Czech Republic $u Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000235619482 $7 xx0238808
- 245 10
- $a Long-Term Antibody Response and Vaccination Efficacy in Patients with COVID-19: A Single Center One-Year Prospective Study from the Czech Republic / $c M. Fajfr, R. Sleha, S. Janovska, V. Koblizek, M. Skala, S. Plisek, P. Prasil, P. Smahel, P. Bostik
- 520 9_
- $a BACKGROUND: The diagnosis of SARS-CoV-2 is almost exclusively performed by PCR or antigen detection. The detection of specific antibodies has not yet been considered in official diagnostic guidelines as major laboratory evidence for a case definition. The aim the present study is to analyze antibody responses in outpatient and inpatient cohorts of COVID-19 patients in the Czech Republic over a 12-month period, and assess the potential of antibodies as a diagnostic tool. METHODS: A total of 644 patients was enrolled in the prospective study. IgA, IgM and IgG antibody levels, as well as virus neutralization titers, were analyzed over a 12-month period. RESULTS: Our study showed low antibody positivity levels at the admission. However, at 2 weeks after infection, 98.75% and 95.00% of hospitalized patients were IgA and IgG positive, respectively. Even in the outpatient cohort characterized by milder disease courses, the IgG antibody response was still sustained at 9 and 12 months. The data show a high correlation between the IgG levels and virus neutralization titers (VNTs). Samples from later time-points showed positive antibody responses after vaccination in both cohorts characterized by high IgG levels and VNT over 1:640. The samples from unvaccinated persons indicated a relatively high level of reinfection at 6.87%. CONCLUSIONS: Our results show that the detection of antibodies against the SARS-CoV-2 shows an increasing sensitivity from week 2 after infection and remains highly positive over the 12-month period. The levels of IgG antibodies correlate significantly with the VNTs. This suggests that the serological data may be a valuable tool in the diagnosis of SARS-CoV-2 infection.
- 650 _2
- $a protilátky virové $7 D000914
- 650 12
- $a tvorba protilátek $7 D000917
- 650 12
- $a COVID-19 $x diagnóza $x epidemiologie $7 D000086382
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a vakcinace $7 D014611
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sleha, Radek $u Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, 50001 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000173599147
- 700 1_
- $a Janovska, Sylva $u Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, 50001 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000323848875 $7 xx0033210
- 700 1_
- $a Koblizek, Vladimir $u Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Department of Pneumology, University Hospital, 50005 Hradec Kralove, Czech Republic
- 700 1_
- $a Skala, Mikulas $u Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Department of Pneumology, University Hospital, 50005 Hradec Kralove, Czech Republic
- 700 1_
- $a Plisek, Stanislav $u Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Department of Infectious Diseases, University Hospital, 50005 Hradec Kralove, Czech Republic
- 700 1_
- $a Prasil, Petr $u Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Department of Infectious Diseases, University Hospital, 50005 Hradec Kralove, Czech Republic
- 700 1_
- $a Smahel, Petr $u Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Department of Infectious Diseases, University Hospital, 50005 Hradec Kralove, Czech Republic
- 700 1_
- $a Bostik, Pavel $u Institute of Clinical Microbiology, University Hospital, 50005 Hradec Kralove, Czech Republic $u Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, 50001 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000326916458
- 773 0_
- $w MED00177099 $t Viruses $x 1999-4915 $g Roč. 14, č. 3 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35336932 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135436 $b ABA008
- 999 __
- $a ok $b bmc $g 1822710 $s 1170473
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 14 $c 3 $e 20220304 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
- GRA __
- $a MH-CZ DRO (UHHK, 00179906) $p Ministry of Health Czech Republic
- GRA __
- $a Long-term organisational development plan (DZRO) $p Ministry of Defence
- LZP __
- $a Pubmed-20220720